P514: V-FAST MASTER TRIAL: PRELIMINARY RESULTS OF TREATMENT WITH CPX-351 PLUS MIDOSTAURIN IN ADULTS WITH NEWLY DIAGNOSED FLT3-MUTATED ACUTE MYELOID LEUKEMIA

Bibliographic Details
Main Authors: J. McCloskey, V. Pullarkat, G. Mannis, T. L. Lin, S. A. Strickland, A. T. Fathi, H. P. Erba, S. Faderl, D. Chakravarthy, Y. Lutska, V. Chandrasekaran, R. S. Cheung, M. Levis
Format: Article
Language:English
Published: Wiley 2022-06-01
Series:HemaSphere
Online Access:http://journals.lww.com/10.1097/01.HS9.0000844944.65720.85
_version_ 1827336896909410304
author J. McCloskey
V. Pullarkat
G. Mannis
T. L. Lin
S. A. Strickland
A. T. Fathi
H. P. Erba
S. Faderl
D. Chakravarthy
Y. Lutska
V. Chandrasekaran
R. S. Cheung
M. Levis
author_facet J. McCloskey
V. Pullarkat
G. Mannis
T. L. Lin
S. A. Strickland
A. T. Fathi
H. P. Erba
S. Faderl
D. Chakravarthy
Y. Lutska
V. Chandrasekaran
R. S. Cheung
M. Levis
author_sort J. McCloskey
collection DOAJ
first_indexed 2024-03-07T18:41:08Z
format Article
id doaj.art-07df082019d54b7f99a42864456223eb
institution Directory Open Access Journal
issn 2572-9241
language English
last_indexed 2024-03-07T18:41:08Z
publishDate 2022-06-01
publisher Wiley
record_format Article
series HemaSphere
spelling doaj.art-07df082019d54b7f99a42864456223eb2024-03-02T03:51:50ZengWileyHemaSphere2572-92412022-06-01641341410.1097/01.HS9.0000844944.65720.85202206003-00413P514: V-FAST MASTER TRIAL: PRELIMINARY RESULTS OF TREATMENT WITH CPX-351 PLUS MIDOSTAURIN IN ADULTS WITH NEWLY DIAGNOSED FLT3-MUTATED ACUTE MYELOID LEUKEMIAJ. McCloskey0V. Pullarkat1G. Mannis2T. L. Lin3S. A. Strickland4A. T. Fathi5H. P. Erba6S. Faderl7D. Chakravarthy8Y. Lutska9V. Chandrasekaran10R. S. Cheung11M. Levis121 John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ2 City of Hope Comprehensive Cancer Center, Duarte, CA3 Stanford University Medical Center, Palo Alto, CA4 University of Kansas Medical Center, Kansas City, KS5 Vanderbilt-Ingram Cancer Center, Nashville, TN6 Massachusetts General Hospital Cancer Center/Harvard Medical School, Boston, MA7 Duke University School of Medicine, Durham, NC8 Jazz Pharmaceuticals, Palo Alto, CA8 Jazz Pharmaceuticals, Palo Alto, CA9 Jazz Pharmaceuticals, Philadelphia, PA9 Jazz Pharmaceuticals, Philadelphia, PA8 Jazz Pharmaceuticals, Palo Alto, CA10 Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, United States of Americahttp://journals.lww.com/10.1097/01.HS9.0000844944.65720.85
spellingShingle J. McCloskey
V. Pullarkat
G. Mannis
T. L. Lin
S. A. Strickland
A. T. Fathi
H. P. Erba
S. Faderl
D. Chakravarthy
Y. Lutska
V. Chandrasekaran
R. S. Cheung
M. Levis
P514: V-FAST MASTER TRIAL: PRELIMINARY RESULTS OF TREATMENT WITH CPX-351 PLUS MIDOSTAURIN IN ADULTS WITH NEWLY DIAGNOSED FLT3-MUTATED ACUTE MYELOID LEUKEMIA
HemaSphere
title P514: V-FAST MASTER TRIAL: PRELIMINARY RESULTS OF TREATMENT WITH CPX-351 PLUS MIDOSTAURIN IN ADULTS WITH NEWLY DIAGNOSED FLT3-MUTATED ACUTE MYELOID LEUKEMIA
title_full P514: V-FAST MASTER TRIAL: PRELIMINARY RESULTS OF TREATMENT WITH CPX-351 PLUS MIDOSTAURIN IN ADULTS WITH NEWLY DIAGNOSED FLT3-MUTATED ACUTE MYELOID LEUKEMIA
title_fullStr P514: V-FAST MASTER TRIAL: PRELIMINARY RESULTS OF TREATMENT WITH CPX-351 PLUS MIDOSTAURIN IN ADULTS WITH NEWLY DIAGNOSED FLT3-MUTATED ACUTE MYELOID LEUKEMIA
title_full_unstemmed P514: V-FAST MASTER TRIAL: PRELIMINARY RESULTS OF TREATMENT WITH CPX-351 PLUS MIDOSTAURIN IN ADULTS WITH NEWLY DIAGNOSED FLT3-MUTATED ACUTE MYELOID LEUKEMIA
title_short P514: V-FAST MASTER TRIAL: PRELIMINARY RESULTS OF TREATMENT WITH CPX-351 PLUS MIDOSTAURIN IN ADULTS WITH NEWLY DIAGNOSED FLT3-MUTATED ACUTE MYELOID LEUKEMIA
title_sort p514 v fast master trial preliminary results of treatment with cpx 351 plus midostaurin in adults with newly diagnosed flt3 mutated acute myeloid leukemia
url http://journals.lww.com/10.1097/01.HS9.0000844944.65720.85
work_keys_str_mv AT jmccloskey p514vfastmastertrialpreliminaryresultsoftreatmentwithcpx351plusmidostaurininadultswithnewlydiagnosedflt3mutatedacutemyeloidleukemia
AT vpullarkat p514vfastmastertrialpreliminaryresultsoftreatmentwithcpx351plusmidostaurininadultswithnewlydiagnosedflt3mutatedacutemyeloidleukemia
AT gmannis p514vfastmastertrialpreliminaryresultsoftreatmentwithcpx351plusmidostaurininadultswithnewlydiagnosedflt3mutatedacutemyeloidleukemia
AT tllin p514vfastmastertrialpreliminaryresultsoftreatmentwithcpx351plusmidostaurininadultswithnewlydiagnosedflt3mutatedacutemyeloidleukemia
AT sastrickland p514vfastmastertrialpreliminaryresultsoftreatmentwithcpx351plusmidostaurininadultswithnewlydiagnosedflt3mutatedacutemyeloidleukemia
AT atfathi p514vfastmastertrialpreliminaryresultsoftreatmentwithcpx351plusmidostaurininadultswithnewlydiagnosedflt3mutatedacutemyeloidleukemia
AT hperba p514vfastmastertrialpreliminaryresultsoftreatmentwithcpx351plusmidostaurininadultswithnewlydiagnosedflt3mutatedacutemyeloidleukemia
AT sfaderl p514vfastmastertrialpreliminaryresultsoftreatmentwithcpx351plusmidostaurininadultswithnewlydiagnosedflt3mutatedacutemyeloidleukemia
AT dchakravarthy p514vfastmastertrialpreliminaryresultsoftreatmentwithcpx351plusmidostaurininadultswithnewlydiagnosedflt3mutatedacutemyeloidleukemia
AT ylutska p514vfastmastertrialpreliminaryresultsoftreatmentwithcpx351plusmidostaurininadultswithnewlydiagnosedflt3mutatedacutemyeloidleukemia
AT vchandrasekaran p514vfastmastertrialpreliminaryresultsoftreatmentwithcpx351plusmidostaurininadultswithnewlydiagnosedflt3mutatedacutemyeloidleukemia
AT rscheung p514vfastmastertrialpreliminaryresultsoftreatmentwithcpx351plusmidostaurininadultswithnewlydiagnosedflt3mutatedacutemyeloidleukemia
AT mlevis p514vfastmastertrialpreliminaryresultsoftreatmentwithcpx351plusmidostaurininadultswithnewlydiagnosedflt3mutatedacutemyeloidleukemia